Form 8-K - Current report:
SEC Accession No. 0001104659-25-039098
Filing Date
2025-04-25
Accepted
2025-04-25 09:29:13
Documents
17
Period of Report
2025-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513177d1_8k.htm   iXBRL 8-K 40106
2 EXHIBIT 10.1 tm2513177d1_ex10-1.htm EX-10.1 268697
3 EXHIBIT 10.2 tm2513177d1_ex10-2.htm EX-10.2 186076
4 EXHIBIT 10.3 tm2513177d1_ex10-3.htm EX-10.3 96126
5 EXHIBIT 99.1 tm2513177d1_ex99-1.htm EX-99.1 10058
  Complete submission text file 0001104659-25-039098.txt   896542

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vstm-20250425.xsd EX-101.SCH 3014
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vstm-20250425_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vstm-20250425_pre.xml EX-101.PRE 22358
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2513177d1_8k_htm.xml XML 3675
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35403 | Film No.: 25870512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)